Adarx 制药 ADRX
$13.23 −$0.06 (-0.45%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $13.23 0.00%
开盘$13.73
昨收$13.29
当日区间$12.50 – $13.73
成交量440.0K
市值$1.35B
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$746,000.00+258.7% YoY
营业利润-$29.89M-41.5% YoY
净利润-$25.76M-42.4% YoY
摊薄每股收益-$0.24-0.4% YoY
自由现金流-$27.56M-108.8% YoY
经营现金流-$27.19M
营收，近4个季度
净利润，近4个季度
各季度摊薄每股收益
各季度自由现金流
盈利能力与资产负债表
营业利润率-1,735.0%
净利率-1,434.1%
资产收益率-19.3%
流动比率12.98
负债/资产比率155.0%
现金及投资$427.25M
总负债$5.19M
净现金（净负债）$422.07M
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| -预付资产变动 | -$1.37M | $493,000.00 | -$3.69M | -$4.50M | $1.75M |
| 营运资金变动 | -$3.59M | -$1.36M | $329.81M | $330.53M | $1.64M |
| 折旧、折耗与摊销 | $735,000.00 | $720,000.00 | $2.33M | $626,000.00 | $514,000.00 |
| 持续经营净利润 | -$25.76M | -$22.67M | -$73.09M | -$18.09M | -$15.55M |
| 持续经营经营活动现金流净额 | -$27.19M | -$22.68M | $262.29M | $313.44M | -$12.71M |
| 经营活动现金流 | -$27.19M | -$22.68M | $262.29M | $313.44M | -$12.71M |
| -应付账款及应计费用变动 | $514,000.00 | $730,000.00 | $4.36M | $698,000.00 | $1.33M |
| 自由现金流 | -$27.56M | -$22.76M | $259.35M | $312.45M | -$13.20M |
| 汇率变动影响 | $47,000.00 | $61,000.00 | $23,000.00 | $18,000.00 | -$6,000.00 |
| 现金净变动 | -$5.42M | -$2.72M | $52.46M | $50.36M | $1.24M |
| 投资购置及出售净额 | $22.13M | $20.04M | -$206.99M | -$262.17M | $14.44M |
| 筹资活动现金流 | $6,000.00 | $2,000.00 | $97,000.00 | $83,000.00 | $0.00 |
| 持续经营筹资活动现金流净额 | $6,000.00 | $2,000.00 | $97,000.00 | $83,000.00 | $0.00 |
| 期初现金余额 | $63.86M | $66.52M | $14.03M | $15.27M | $14.03M |
| 固定资产购置及出售净额 | -$367,000.00 | -$77,000.00 | -$2.94M | -$992,000.00 | -$497,000.00 |
| 期末现金余额 | $58.48M | $63.86M | $66.52M | $65.65M | $15.27M |
| 持续经营投资活动现金流净额 | $21.76M | $19.96M | -$209.93M | -$263.17M | $13.94M |
| 股票期权行使所得 | $6,000.00 | $2,000.00 | $97,000.00 | $83,000.00 | $0.00 |
| 投资活动现金流净额 | $21.76M | $19.96M | -$209.93M | -$263.17M | $13.94M |
| -其他营运资金变动 | -$746,000.00 | -$2.14M | $331.55M | – | – |
| -其他流动负债变动 | -$430,000.00 | -$412,000.00 | -$862,000.00 | -$370,000.00 | -$128,000.00 |
| -其他流动资产变动 | -$1.57M | -$30,000.00 | -$1.55M | -$91,000.00 | -$1.32M |
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| 非经营性利息收入 | $3.78M | $3.98M | $13.64M | $2.48M | $2.27M |
| 其他收入（支出） | $355,000.00 | $411,000.00 | $1.64M | $553,000.00 | $72,000.00 |
| 其他非经营性收入（支出） | $355,000.00 | $411,000.00 | $1.64M | $553,000.00 | $72,000.00 |
| 税前利润 | -$25.76M | -$22.67M | -$73.09M | -$18.09M | -$15.55M |
| 归属母公司净利润 | -$25.76M | -$22.67M | -$73.09M | -$18.09M | -$15.55M |
| 归属普通股股东净利润 | -$25.76M | -$22.67M | -$73.09M | -$18.09M | -$15.55M |
| 基本每股收益 | -$0.24 | -$0.21 | -$0.97 | -$0.24 | -$0.21 |
| 摊薄每股收益 | -$0.24 | -$0.21 | -$0.97 | -$0.24 | -$0.21 |
| 非经营性利息净收入（支出） | $3.78M | $3.98M | $13.64M | $2.48M | $2.27M |
| 营业利润 | -$29.89M | -$27.06M | -$88.37M | -$21.12M | -$17.89M |
| 持续经营利润 | -$25.76M | -$22.67M | -$73.09M | -$18.09M | -$15.55M |
| 报告营业总收入 | $746,000.00 | $2.14M | $3.45M | $208,000.00 | $0.00 |
| 营业总收入 | $746,000.00 | $2.14M | $3.45M | $208,000.00 | $0.00 |
| 营业费用 | $30.64M | $29.20M | $91.81M | $21.33M | $17.89M |
| 销售及管理费用 | $5.90M | $5.62M | $20.30M | $4.26M | $5.00M |
| -管理费用 | $5.90M | $5.62M | $20.30M | $4.26M | $5.00M |
| 研发费用 | $24.74M | $23.58M | $71.51M | $17.07M | $12.89M |
| 净利润 | -$25.76M | -$22.67M | -$73.09M | -$18.09M | -$15.55M |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2024 ANNUAL |
|---|---|---|---|---|
| 现金及现金等价物与短期投资 | $427.25M | $455.82M | $480.00M | $219.48M |
| 不影响留存收益的损益 | -$783,000.00 | $306,000.00 | $1.96M | $335,000.00 |
| 留存收益 | -$269.13M | -$243.37M | -$220.70M | -$147.61M |
| 资本公积 | $18.86M | $17.33M | $16.49M | $10.13M |
| -普通股 | $0.00 | $0.00 | $0.00 | $0.00 |
| -应付账款 | $4.86M | $6.77M | $5.84M | $1.35M |
| 应付款 | $4.86M | $6.77M | $5.84M | $1.35M |
| 流动负债合计 | $34.01M | $29.76M | $30.49M | $8.94M |
| 负债合计 | $707.38M | $708.29M | $709.91M | $370.60M |
| 其他非流动资产 | $3.81M | $2.24M | $2.21M | $660,000.00 |
| -累计折旧 | -$4.13M | -$3.84M | -$3.54M | -$2.54M |
| -固定资产原值 | $15.11M | $15.44M | $15.61M | $9.67M |
| 固定资产净值 | $10.98M | $11.60M | $12.07M | $7.13M |
| 非流动资产合计 | $14.79M | $13.84M | $14.28M | $7.79M |
| 其他流动资产 | $14.29M | $12.90M | $13.38M | $6.19M |
| -短期投资 | $368.77M | $391.96M | $413.48M | $205.44M |
| 总资产 | $456.33M | $482.56M | $507.66M | $233.45M |
| 一年内应计费用 | $5.36M | $4.33M | $3.49M | $3.50M |
| 短期债务及融资租赁负债 | $1.71M | $1.71M | $1.71M | $794,000.00 |
| 股本 | $0.00 | $0.00 | $0.00 | $0.00 |
| 股东权益 | -$251.05M | -$225.73M | -$202.26M | -$137.15M |
| 股东权益合计 | -$251.05M | -$225.73M | -$202.26M | -$137.15M |
| 其他非流动负债 | $805,000.00 | $801,000.00 | $781,000.00 | $505,000.00 |
| 可转换优先证券 | $357.62M | $357.62M | $357.62M | $357.62M |
| 一年以上递延负债 | $309.76M | $314.50M | $314.99M | $0.00 |
| -长期融资租赁负债 | $5.19M | $5.62M | $6.03M | $3.54M |
| 流动资产合计 | $441.54M | $468.72M | $493.38M | $225.67M |
| 长期债务及融资租赁负债 | $5.19M | $5.62M | $6.03M | $3.54M |
| 非流动负债合计 | $673.37M | $678.54M | $679.43M | $361.66M |
| 一年内递延负债 | $18.91M | $14.92M | $16.56M | $0.00 |
| -一年内到期融资租赁负债 | $1.71M | $1.71M | $1.71M | $794,000.00 |
| -现金及现金等价物 | $58.48M | $63.86M | $66.52M | $14.03M |
暂无评论——快来第一个聊聊 ADRX。
登录后参与讨论。